The peroxisome proliferator-activated receptor alpha agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lung-Reference-Cited by-同舟云学术

The peroxisome proliferator-activated receptor alpha agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lung

Published:2011-03-11 Issue:3 Volume:26 Page:340-346
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:

Author:

Becker Julien,Delayre-Orthez Carine,Frossard Nelly,Pons Françoise

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1472-8206.2011.00935.x/fullpdf

Reference34 articles.

1. Peroxisome proliferator-activated receptors: nuclear control of metabolism;Desvergne;Endocr. Rev.,1999

2. Nuclear receptors and the control of metabolism;Francis;Annu. Rev. Physiol.,2003

3. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb;Madej;Int. J. Clin. Pharmacol. Ther.,1998

4. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators;Staels;Nature,1998

5. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models;Sheu;J. Invest. Dermatol.,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenofibrate attenuates asthma features in an ovalbumin-induced mouse model via suppressing NF-κB binding activity;Respiratory Physiology & Neurobiology;2023-08

2. Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation;International Immunopharmacology;2022-07

3. Pemafibrate Attenuates Pulmonary Fibrosis by Inhibiting Myofibroblast Differentiation;SSRN Electronic Journal;2022

4. Chinese Herbs and Repurposing Old Drugs as Therapeutic Agents in the Regulation of Oxidative Stress and Inflammation in Pulmonary Diseases;Journal of Inflammation Research;2021-03

5. Exercise as medicine for COVID-19: On PPAR with emerging pharmacotherapy;Medical Hypotheses;2020-10